Carregant...
PD-L1 Inhibition with Avelumab for Metastatic Merkel Cell Carcinoma
INTRODUCTION: Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine skin cancer that lacks durable responses to traditional chemotherapy. AREAS COVERED: After MCC was shown to be an immunogenic tumor, small trials revealed high objective response rates to PD-1/PD-L1 checkpoint inhibito...
Guardat en:
| Publicat a: | Expert Rev Clin Pharmacol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6360093/ https://ncbi.nlm.nih.gov/pubmed/29478343 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17512433.2018.1445966 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|